Vanguard Capital Management
CSBR icon

Vanguard Capital Management’s Champions Oncology CSBR Stock Holding History

Vanguard Capital Management’s Portfolio CSBR Stock Details CSBR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.86M Buy
301,353
+1,833
+0.6% +$11.1K ﹤0.01% 3447
2026
Q1 		$1.72M Buy
+299,520
New +$1.9M ﹤0.01% 3412

Other funds holding CSBR

TAM
Tocqueville Asset Management New York $7.56B AUM 44.87% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MBAM
Mink Brook Asset Management West Palm Beach, Florida $227M AUM 64.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management's CSBR Position: Q2 2026 in Review

Vanguard Capital Management increased its Champions Oncology (CSBR) stake by 0.61% in Q2 2026, buying an estimated $11.1K and bringing the position to 301,353 shares worth $1.86M. The position accounts for ﹤0.01% of the portfolio, ranked #3447.

Vanguard Capital Management first reported a position in CSBR in Q1 2026 and has held it in 2 quarters since. 23 funds tracked by Wall St. Rank hold CSBR as of Q2 2026.

  • Vanguard Capital Management held 301,353 shares of Champions Oncology worth $1.86M as of Q2 2026.
  • Vanguard Capital Management bought 1,833 Champions Oncology shares in Q2 2026, an estimated $11.1K.
  • Champions Oncology made up ﹤0.01% of Vanguard Capital Management's portfolio in Q2 2026, its #3447 holding.
  • Vanguard Capital Management first reported a position in Champions Oncology in Q1 2026 and has held it in 2 quarters since.
  • 23 funds tracked by Wall St. Rank held Champions Oncology as of Q2 2026.

Based on Vanguard Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.